3/19/24 18:44 | 3/18/24 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S | -47 | 5.04 | 0 | -9 | -5 | 193 | D | | | | | | | | | | | | | | |
7/5/23 21:11 | 7/3/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S | -43 | 25.04 | 0 | -2 | -2 | 80 | D | | | | | | | | | | | | | | |
6/5/23 18:06 | 6/1/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S.m | -98 | 30.64 | 0 | -3 | -4 | 81 | D | | | | | | | | | | | | | | |
5/16/23 20:29 | 5/15/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S | -739 | 34.55 | 0 | -21 | -20 | 84 | D | | | | | | | | | | | | | | |
5/2/23 16:01 | 5/1/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S | -101 | 31.70 | 0 | -3 | -5 | 63 | D | | | | | | | | | | | | | | |
4/4/23 16:24 | 4/3/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S | -103 | 32.15 | 0 | -3 | -5 | 66 | D | | | | | | | | | | | | | | |
3/9/23 21:46 | 3/9/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S | -585 | 31.59 | 0 | -19 | -20 | 73 | D | | | | | | | | | | | | | | |
3/2/23 21:25 | 3/1/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S | -107 | 33.50 | 0 | -3 | -6 | 49 | D | | | | | | | | | | | | | | |
2/2/23 21:38 | 2/1/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S.d | -111 | 34.60 | 0 | -3 | -6 | 55 | D | | | | | | | | | | | | | | |
1/23/23 17:35 | 1/20/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S | -31 | 31.00 | 0 | -1 | -2 | 58 | D | | | | | | | | | | | | | | |
1/10/23 20:06 | 1/9/23 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | S | -101 | 27.16 | 0 | -4 | -6 | 59 | D | | | | | | | | | | | | | | |
6/28/18 16:20 | 6/26/18 | AKAO | Achaogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | CA | O | CFO | S.d | -3 | 9.59 | 0 | 0 | -1 | 48 | D | | | | | | | | | | | | | | |
6/13/18 17:03 | 6/11/18 | AKAO | Achaogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | CA | O | CFO | S | -25 | 11.95 | 0 | -2 | -4 | 47 | D | | | | | | | | | | | | | | |
2/23/18 20:38 | 2/21/18 | AKAO | Achaogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | CA | O | CFO | S | -12 | 10.67 | 0 | -1 | -3 | 40 | D | | | | | | | | | | | | | | |
6/14/17 19:39 | 6/12/17 | AKAO | Achaogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | CA | O | CFO | S | -44 | 21.53 | 0 | -2 | -5 | 40 | D | | | | | | | | | | | | | | |
1/30/17 21:38 | 1/26/17 | AKAO | Achaogen Inc | DE | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | CA | O | CFO | S | -16 | 16.78 | 20 | -1 | -4 | 26 | D | 35 | 304 | 302 | 175 | 10 | 3 | -11 | -8 | 4 | 12 | 51 | 55 | | |